The most important China is preparing to open vaccination to children from 3 years old. This makes it the first country in the world to vaccinate young children.
This is an important step that China will take. The country where Covid-19 has occurred will, according to an announcement by the pharmaceutical company Sinovac, open vaccinations for children from 3 years of age: “The Sinovac vaccine has been approved in the last few days for the ages of three to 17,” announced this on Tuesday June 8, a company spokesman. Sinovac is one of three vaccines currently approved in China.
First successful test in March
The country has already given almost 800 million vaccine doses against Covid-19, which until then were only available to people over the age of 18. Beijing has practically wiped out the epidemic on its soil since May 2020 and is hoping to vaccinate at least 70% of its population, or around a billion people, by the end of the year.
Also read: Vaccination of young people: The ethics committee “regrets” the speed of the decision
The Sinovac spokesman did not specify when the first doses could be given to children, the schedule is in the hands of the Ministry of Health, he said. The laboratory has completed its clinical studies with children and adolescents, the results of which are due to be published in the British journal The Lancet, he added. A first conclusive study was carried out in March on 550 patients aged 3 to 17 years.
Twenty Chinese vaccine candidates are in clinical trials
In addition to Sinovac, China has so far approved the administration of adult vaccines made by its Sinopharm (two-dose) and Cansino Biologics (one-dose) laboratories. These laboratories have also initiated clinical studies on minors. In total, there are around 20 Chinese vaccine candidates in the clinical trial phase, Ministry of Health official Zheng Zhongwei said on Sunday.
Also read: INFOGRAPHY. Deconfinance: curfew, travel, restaurants, gyms … discover everything that changes this Wednesday
Sinovac and Sinopharm products have been approved by the World Health Organization (WHO) for use in adults. Both are used in several countries around the world. Elsewhere in the world, the European Union, the United States, and the United Kingdom have approved the use of the Pfizer / BioNTech vaccine in children 12 years and older.